1. Home
  2. APM vs OBLG Comparison

APM vs OBLG Comparison

Compare APM & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • OBLG
  • Stock Information
  • Founded
  • APM 2010
  • OBLG 2000
  • Country
  • APM United Kingdom
  • OBLG United States
  • Employees
  • APM N/A
  • OBLG N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • APM Health Care
  • OBLG Technology
  • Exchange
  • APM Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • APM 4.1M
  • OBLG 4.4M
  • IPO Year
  • APM 2018
  • OBLG N/A
  • Fundamental
  • Price
  • APM $1.15
  • OBLG $3.60
  • Analyst Decision
  • APM
  • OBLG
  • Analyst Count
  • APM 0
  • OBLG 0
  • Target Price
  • APM N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • APM 7.0M
  • OBLG 34.7K
  • Earning Date
  • APM 12-20-2024
  • OBLG 11-07-2024
  • Dividend Yield
  • APM N/A
  • OBLG N/A
  • EPS Growth
  • APM N/A
  • OBLG N/A
  • EPS
  • APM 0.00
  • OBLG N/A
  • Revenue
  • APM N/A
  • OBLG $2,759,000.00
  • Revenue This Year
  • APM $157,729.10
  • OBLG N/A
  • Revenue Next Year
  • APM N/A
  • OBLG N/A
  • P/E Ratio
  • APM $345.64
  • OBLG N/A
  • Revenue Growth
  • APM N/A
  • OBLG N/A
  • 52 Week Low
  • APM $0.46
  • OBLG $2.81
  • 52 Week High
  • APM $17.49
  • OBLG $14.80
  • Technical
  • Relative Strength Index (RSI)
  • APM 47.12
  • OBLG 47.86
  • Support Level
  • APM $1.21
  • OBLG $3.33
  • Resistance Level
  • APM $1.30
  • OBLG $4.04
  • Average True Range (ATR)
  • APM 0.75
  • OBLG 0.33
  • MACD
  • APM -0.06
  • OBLG -0.04
  • Stochastic Oscillator
  • APM 4.58
  • OBLG 29.35

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. Mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, real estate.

Share on Social Networks: